Immunogenicity of synthetic conjugates of Lewisy oligosaccharide with proteins in mice: towards the design of anticancer vaccines Valery KudryashovHyunjin M. KimK. O. Lloyd ORIGINAL ARTICLE Pages: 281 - 286
Doxorubicin plus tumor necrosis factor α combination treatments in EL4-lymphoma-bearing C57BL/6 mice M. J. EhrkeSrdan VerstovšekEnrico Mihich ORIGINAL ARTICLE Pages: 287 - 298
Alteration of signal-transducing molecules in tumor-infiltrating lymphocytes and peripheral blood T lymphocytes from human colorectal carcinoma patients S. H. ChoiEun Joo ChungC. W. Kim ORIGINAL ARTICLE Pages: 299 - 305
Transforming growth factor β , (TGFβ) secreted by immunogenic ex vivo human carcinoma cells, counteracts the activation and inhibits the function of autologous cytotoxic lymphocytes. Pretreatment with interferon γ and tumor necrosis factor α reduces the production of active TGFβ Noémi NagyF. Vánky ORIGINAL ARTICLE Pages: 306 - 312
A novel glycoprotein obtained from Chlorella vulgaris strain CK22 shows antimetastatic immunopotentiation K. TanakaAkira YamadaKikuo Nomoto ORIGINAL ARTICLE Pages: 313 - 320
Parameters for using mannan-MUC1 fusion protein to induce cellular immunity G. A. PieterszWenjun LiIan F. C. McKenzie ORIGINAL ARTICLE Pages: 321 - 326
Superiority of the ear pinna over a subcutaneous tumour inoculation site for induction of a Th1-type cytokine response K. JurianzP. von HoegenV. Schirrmacher ORIGINAL ARTICLE Pages: 327 - 333
FC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewisx hapten Mariana CapurroLaura BoverJ. Mordoh ORIGINAL ARTICLE Pages: 334 - 339